RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2-Negative, Locally Recurrent or Metastatic Breast Cancer
Robert, N. J., Dieras, V., Glaspy, J., Brufsky, A. M., Bondarenko, I., Lipatov, O. N., Perez, E. A., Yardley, D. A., Chan, S. Y. T., Zhou, X., Phan, S.-C., O'Shaughnessy, J.Volume:
29
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2010.28.0982
Date:
April, 2011
File:
PDF, 317 KB
english, 2011